Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 220 of 1,261

  1. US 11530421

    Self-inactivating endonuclease-encoding nucleic acids and methods of using the same

    The Regents of the University of California · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  2. US 11530259

    Therapies and methods to treat TLR2-mediated diseases and disorders

    The Regents of the University of California · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  3. US 11530244

    Cyclic polypeptides for PCSK9 inhibition

    RA PHARMACEUTICALS, INC. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  4. US 11529363

    Methods of treating cancer in pediatric patients

    Takeda Pharmaceutical Company Limited · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  5. US 11528924

    Alcoholic beverage substitutes

    CLEARMIND MEDICINE INC. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  6. US 11529360

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  7. US 11530424

    Efficient CRISPR/HDR-mediated knock-in system and method of use

    United States Department of Veteran Affairs · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  8. US 11530411

    Methods for reducing LRRK2 expression

    Ionis Pharmaceuticals, Inc. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  9. US 11530410

    Methods for treating hypercholesterolemia

    Ionis Pharmaceuticals, Inc. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  10. US 11530408

    Therapeutic compositions

    Alnylam Pharmaceuticals, Inc. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  11. US 11530398

    CRISPR-Cas effector polypeptides and methods of use thereof

    The Regents of the University of California · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  12. US 11530393

    Compositions comprising iduronate-2-sulfatase

    Takeda Pharmaceutical Company Limited · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  13. US 11530240

    Catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering

    The Regents of the University of California · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  14. US 11530229

    Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof

    NURIX THERAPEUTICS, INC. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  15. US 11530248

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  16. US 11530196

    Pyrimidine compound acting on EGFR and ERBB2

    CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LIMITED · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  17. US 11529417

    Wound healing through sirt1 overexpression

    Northwestern University · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  18. US 11530194

    Amide compounds and method for making and using

    Rigel Pharmaceuticals, Inc. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  19. US 11529427

    Gene editing for hemophilia A with improved factor VIII expression

    CRISPR THERAPEUTICS AG · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  20. US 11529395

    Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF

    Takeda Pharmaceutical Company Limited · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  21. US 11529375

    Compositions and methods for treating diverticulitis and related disorders

    Finch Therapeutics Holdings LLC · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  22. US 11529373

    Method for enhancing expression of insulin like growth factor 1 receptor in mesenchymal stem cell, method for obtaining mesenchymal stem cell, and method for treating brain tissue damage

    China Medical University · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  23. US 11529372

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  24. US 11529312

    Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.